Discontinuation report TEVA-VENLAFAXINE XR

Last updated on 2020-02-08 History
Report ID 105537
Drug Identification Number 02275031
Brand name TEVA-VENLAFAXINE XR
Common or Proper name VENLAFAXINE XR 75MG CAPS
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) VENLAFAXINE
Strength(s) 75MG
Dosage form(s) CAPSULE (EXTENDED RELEASE)
Route of administration ORAL
Packaging size 100's & 500's
ATC code N06AX
ATC description ANTIDEPRESSANTS
Reason for discontinuation Business reasons
Anticipated discontinuation date
Actual discontinuation date 2020-02-07
Remaining supply date 2020-02-07
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments Transitioned to the ACT Product
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v3 2020-02-08 English Compare
v2 2020-02-07 French Compare
v1 2020-02-07 English Compare